相关实验视频

Updated: May 1, 2026

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

对于B细胞枯竭患者的COVID-19康复性血:系统性审查和个人患者数据元分析

Solomiia Zaremba¹, Daniele Focosi², Wyatt W Pruter¹

¹Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, United States.

Frontiers in medicine

|November 3, 2025

概括

疫苗增强的COVID-19康复性血 (CCP) 显著改善了B细胞枯竭患者的生存率. 这一发现为具有高SARS-CoV-2并发症风险的免疫功能低下个体提供了关键的治疗选择.

科学领域:

免疫学免疫学免疫学
传染性疾病传染性疾病
血液学血液学血液学

背景情况:

COVID-19康复性血 (CCP) 是一种已被认可的SARS-CoV-2治疗方法.
B细胞枯竭的患者的抗体产生受损,增加了他们对感染的脆弱性.
疫苗增强的CCP,来自感染和接种疫苗的个体,是一种混合产品.

研究的目的:

评估与接受CCP的B细胞枯竭患者60天生存期相关的因素.
在这个特定的患者群体中评估疫苗增强CPC的疗效.

主要方法:

系统审查和个人参与者数据的元分析.
包括对B细胞枯竭患者中CCP使用的研究.
条件后勤回归分析以确定生存预测因素.

主要成果:

在85项研究中,570名患者的整体60天生存率为86.5%.
输血用疫苗增强的CPC显示出与改善60天生存率的显著关联 (OR=9.49,p=0.005).
存活率与之前对免疫受损患者的分析一致.

结论:

疫苗增强的CCP与B细胞枯竭患者的显著生存益处有关.
这一发现突显了疫苗增强的CCP对免疫受损个体的治疗潜力.
进一步的研究可能会优化在弱势患者群体中CPT的利用.

关键词:

B细胞的枯竭导致B细胞的枯竭.在 COVID-19 疫情中,这就是SARS-CoV-2病毒.对抗CD20的治疗方法.康复期间的血.免疫缺陷是一种免疫缺陷.

更多相关视频

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

相关概念视频

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...